HK1005868A1 - Esters of (r)(-)-carnitine and acyl (r)(-)-carnitines with beta-hydroxybutryric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration liver proteolysis and for the treatment of coma - Google Patents
Esters of (r)(-)-carnitine and acyl (r)(-)-carnitines with beta-hydroxybutryric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration liver proteolysis and for the treatment of comaInfo
- Publication number
- HK1005868A1 HK1005868A1 HK98104950A HK98104950A HK1005868A1 HK 1005868 A1 HK1005868 A1 HK 1005868A1 HK 98104950 A HK98104950 A HK 98104950A HK 98104950 A HK98104950 A HK 98104950A HK 1005868 A1 HK1005868 A1 HK 1005868A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- acid
- carnitines
- carnitine
- coma
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT47669A IT1240775B (it) | 1990-02-23 | 1990-02-23 | Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma. |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1005868A1 true HK1005868A1 (en) | 1999-01-29 |
Family
ID=11261785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98104950A HK1005868A1 (en) | 1990-02-23 | 1998-06-05 | Esters of (r)(-)-carnitine and acyl (r)(-)-carnitines with beta-hydroxybutryric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration liver proteolysis and for the treatment of coma |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0443996B1 (xx) |
JP (1) | JP2930755B2 (xx) |
AT (1) | ATE107624T1 (xx) |
DE (1) | DE69102560T2 (xx) |
DK (1) | DK0443996T3 (xx) |
ES (1) | ES2056620T3 (xx) |
HK (1) | HK1005868A1 (xx) |
IT (1) | IT1240775B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1248321B (it) * | 1991-05-15 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie |
IT1254135B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
IT1254136B (it) * | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica. |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
AU749638B2 (en) * | 1997-03-17 | 2002-06-27 | Btg International Limited | Therapeutic compositions |
US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
DE60138019D1 (de) * | 2000-05-01 | 2009-04-30 | Accera Inc | Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung |
EP2001293B9 (en) | 2006-04-03 | 2019-04-17 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
CN1995010B (zh) * | 2006-12-29 | 2012-12-12 | 辽宁科硕营养科技有限公司 | 一种合成丙酰左旋肉碱盐酸盐的方法 |
EP2650381B1 (en) | 2007-07-31 | 2016-09-21 | Accera, Inc. | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
CN102105071A (zh) | 2008-07-03 | 2011-06-22 | 艾克塞拉公司 | 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物 |
CN112341331B (zh) * | 2019-08-07 | 2023-04-07 | 辽宁科硕营养科技股份有限公司 | 一种3-羟基丁酸盐及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
IT1145362B (it) * | 1980-03-06 | 1986-11-05 | Sigma Tau Ind Farmaceuti | Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico |
IT1209564B (it) * | 1984-06-29 | 1989-08-30 | Magis Farmaceutici | Derivati della l-carnitina o di l-acil carnitina. |
-
1990
- 1990-02-23 IT IT47669A patent/IT1240775B/it active IP Right Grant
-
1991
- 1991-02-21 ES ES91830062T patent/ES2056620T3/es not_active Expired - Lifetime
- 1991-02-21 EP EP91830062A patent/EP0443996B1/en not_active Expired - Lifetime
- 1991-02-21 DE DE69102560T patent/DE69102560T2/de not_active Expired - Fee Related
- 1991-02-21 DK DK91830062.5T patent/DK0443996T3/da active
- 1991-02-21 AT AT91830062T patent/ATE107624T1/de not_active IP Right Cessation
- 1991-02-22 JP JP3050644A patent/JP2930755B2/ja not_active Expired - Fee Related
-
1998
- 1998-06-05 HK HK98104950A patent/HK1005868A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT9047669A1 (it) | 1991-08-24 |
JPH0597785A (ja) | 1993-04-20 |
DE69102560T2 (de) | 1994-10-13 |
IT1240775B (it) | 1993-12-17 |
JP2930755B2 (ja) | 1999-08-03 |
ATE107624T1 (de) | 1994-07-15 |
EP0443996B1 (en) | 1994-06-22 |
DE69102560D1 (de) | 1994-07-28 |
EP0443996A1 (en) | 1991-08-28 |
ES2056620T3 (es) | 1994-10-01 |
DK0443996T3 (da) | 1994-07-25 |
IT9047669A0 (it) | 1990-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1005859A1 (en) | Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma | |
HK1005868A1 (en) | Esters of (r)(-)-carnitine and acyl (r)(-)-carnitines with beta-hydroxybutryric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration liver proteolysis and for the treatment of coma | |
CA1252098A (en) | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same | |
HK1005858A1 (en) | Ester of l-carnitine with gamma-hydroxybutyric acid and pharmaceutical compositions containing it for inhibiting neuronal degeneration and for the treatment of coma | |
DE69302883T2 (de) | L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen | |
ITRM910333A1 (it) | Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti | |
GR3021479T3 (en) | Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity | |
DE69207479T2 (de) | Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen | |
DE69410866T2 (de) | Verwendung von Ester von Acyl-L-Carnitin mit Gammahydroxybuttersäure zur Behandlung von Alkoholismus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090221 |